Calcipotriene toxicosis in a dog successfully treated with pamidronate disodium

Journal of Veterinary Emergency and Critical Care

Volumn 12, Issue 3, 2002, Pages 177-181

  Pesillo, S Anna ^a   Khan, Safdar A ^b   Rozanski, Elizabeth A ^a   Rush, John E ^a  

^a TUFTS UNIVERSITY   (United States)

^b ASPCA ANIMAL POISON CONTROL CENTER   (United States)

Author keywords

Bisphosphanates; Hypercalcemia; Vitamin D 3 analog

Indexed keywords

EID: 13544271790     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1046/j.1435-6935.2002.00022.x     Document Type: Article

References (20)

1. Hare WR, Dobbs CE, Slayman KA, et al. Calcipotriene poisoning in dogs. Vet Med 2000; 95(10):770–778.
2. Fan TM, Simpson KW, Trasti A, et al. Calcipotriol toxicity in a dog. J Small Anim Pract 1998; 39(12):581–586.pmid/9888112
3. 3 rodenticide to dogs. J Am Vet Med Assoc 1988; 193(2):211–214.pmid/2841268
4. Fooshee SK, Forrester SD. Hypercalcemia secondary to cholecalciferol rodenticide toxicosis in two dogs. J Am Vet Med Assoc 1990; 196(8):1265–1268.pmid/2158959
5. Chew DJ, Carothers M. Hypercalcemia. Vet Clin North Am Small Anim Pract 1989; 19(2):265–287.pmid/2648666
6. Highton A, Quell J. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. J Am Acad Dermatol 1995; 32(1):67–72.pmid/7822519
7. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37(5):889–895.pmid/2830885
8. Rosol TJ, Chew DJ, Nagode LA, et al. Disorders of Calcium. In: DiBartola SP, ed. Fluid Therapy in Small Animal Practice, 2nd edn. Philadelphia: W.B. Saunders 2000, pp. 108–162.
9. Kruger JM, Osborne CA. Canine and feline hypercalcemic nephropathy. Part I. Causes and consequences. Compend Contin Ed 1994; 16(10):1299–1315.
10. Feldman EC. Disorders of the parathyroid glands. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 4th edn. Philadelphia: W.B. Saunders 1995, pp. 1437–1465.
11. Spangler WL, Gribble DH, Lee TC. Vitamin D intoxication and the pathogenesis of vitamin D nephropathy in the dog. Am J Vet Res 1979; 40(1):73–83.pmid/453687
12. Dorman DC, Beasley VR. Diagnosis and therapy for cholecalciferol toxicosis. In: Kirk, RW, ed. Current Veterinary Therapy X. Philadelphia: W.B. Saunders 1989, pp. 148–152.
13. Willard MD, DiBartola SP. Disorders of Phosphorus. In: DiBartola SP, ed. Fluid Therapy in Small Animal Practice, 2nd edn. Philadelphia: W.B. Saunders Co 2000, pp. 163–174.
14. Doughertry SA, Center SA, Dzanis DA. Salmon calcitonin as adjunct treatment for vitamin D toxicosis in a dog. J Am Vet Med Assoc 1990; 196(8):1269–1272.pmid/2158960
15. Boothe DM, Mealey KA. Glucocorticoid therapy in the dog and cat. In: Boothe DM, ed. Small Animal Clinical Pharmacology and Therapeutics. Philadelphia: W.B. Saunders 2001, p. 316.
16. Deftos LJ, First BP. Calcitonin as a drug. Ann Intern Med 1981; 95(1):192–197.pmid/7258871
17. Rumbeiha WK, Fitzgerald SD, Kruger JM, et al. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs. Am J Vet Res 2000; 61(1):9–13.pmid/10630770
18. Rumbeiha WK, Kruger JM, Fitzgerald SF, et al. Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs. Am J Vet Res 1999; 60(9):1092–1097.pmid/10490077
19. Body JJ, Bartl R, Delmas PD, et al. Current use of bisphosphonates in Oncology. J Clin Oncol 1998; 16(12):3890–3899.pmid/9850035
20. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000; 27(3):322–334.pmid/10864220